|
Volumn 74, Issue SUPPL.1, 2008, Pages 66-71
|
Postmarketing surveillance study of OxyContin® tablets for relieving moderate to severe postherpetic neuralgia pain
|
Author keywords
OxyContin tablets; Pain management; Postherpetic neuralgia pain; Postmarketing surveillance
|
Indexed keywords
FENTANYL;
OXYCODONE;
ADULT;
AGED;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONSTIPATION;
CONTROLLED DRUG RELEASE;
CONTROLLED STUDY;
DIZZINESS;
DRUG DOSE INCREASE;
DRUG DOSE REDUCTION;
DRUG DOSE TITRATION;
DRUG EFFICACY;
DRUG SAFETY;
DYSURIA;
FEMALE;
HUMAN;
MALE;
MULTICENTER STUDY;
NAUSEA;
POSTHERPETIC NEURALGIA;
POSTMARKETING SURVEILLANCE;
PRIORITY JOURNAL;
SKIN PRURITUS;
SOMNOLENCE;
TABLET FORMULATION;
TREATMENT RESPONSE;
UNSPECIFIED SIDE EFFECT;
VISUAL ANALOG SCALE;
VOMITING;
XEROSTOMIA;
ADULT;
AGED;
AGED, 80 AND OVER;
ANALGESICS, OPIOID;
DELAYED-ACTION PREPARATIONS;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASMS;
NEURALGIA, POSTHERPETIC;
OXYCODONE;
PAIN MEASUREMENT;
PRODUCT SURVEILLANCE, POSTMARKETING;
PROSPECTIVE STUDIES;
TABLETS;
|
EID: 50849141692
PISSN: 00302414
EISSN: None
Source Type: Journal
DOI: 10.1159/000143222 Document Type: Conference Paper |
Times cited : (8)
|
References (5)
|